Lowered B-type natriuretic peptide in response to levosimendan or dobutamine treatment is associated with improved survival in patients with severe acutely decompensated heart failure. (Q45962743)

From Wikidata
Revision as of 03:25, 15 August 2019 by Simon Villeneuve (talk | contribs) (‎Created claim: language of work or name (P407): English (Q1860), #petscan)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Lowered B-type natriuretic peptide in response to levosimendan or dobutamine treatment is associated with improved survival in patients with severe acutely decompensated heart failure.
scientific article

    Statements

    title
    Lowered B-type natriuretic peptide in response to levosimendan or dobutamine treatment is associated with improved survival in patients with severe acutely decompensated heart failure. (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed publication ID
    19539144
    retrieved
    18 December 2017
    reference URL
    http://europepmc.org/abstract/MED/19539144

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q45962743&oldid=996566679"